Exploring Psychedelic Therapy for Mental Health
Information
Recorded
-
-
Educational Goal
Participants will gain competency in psychedelic therapy.
Description
What is psychedelic therapy? What does the research tell us about treating mental health conditions with psychedelic-assisted therapies?
Learn the key facts on how MDMA, psilocybin, and ketamine work in the body and how these substances are combined with therapeutic approaches. Become knowledgeable on clinical protocols, safety and efficacy results, study participant accounts, and potential risks in both medical and non-medical settings.
Target Audience
- Counselor
- Marriage & Family Therapist
- Psychologist
- Social Worker
- Substance Use Disorder Professionals
Presenters
Allison Feduccia, Ph.D., is a neuropharmacologist who has authored 28 publications on psychedelics and mental health in peer-reviewed journals. She began researching MDMA in 2004, accumulating 17 years of experience in mental health research at UT Austin, UCSF, NIH, and MAPS. In 2018, she co-founded Psychedelic Support, a platform for education and to connect with psychedelic practitioners, and Project New Day, a 501(c)3 nonprofit foundation with the mission to help people overcome addiction and actualize mental health through responsible and legal use of psychedelics.